Aytu Biopharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.68

+0.03 (+1.13%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +241.4% upside

Low Target $5.34

Average Target $9.15

High Target $10.98

Current Price $2.68

Current
$2.68

Target
$9.15

$5.34 $9.15 avg $10.98

Scenario Analysis

Bear Case

$5.34

99.3%

Low target

Base Case

$9.15

+241.4%

Avg target

Bull Case

$10.98

+309.7%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$3.07

-12.6% from high

52-Week Low

$0.95

+182.1% from low

Target vs 52W High

$9.15

+198.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%